Optimapharm
Optima derm suite bg
OptimaDerm Suite - dermatology CRO and clinical trial platform
Partnered on
85
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Approved Dermatological Therapies

OptimaDerm Suite introduces a fully integrated dermatology Full Service CRO ecosystem that unites medical experts, specialised research sites, meaningful patient engagement, and purpose-built digital solutions into one cohesive platform. Designed to streamline study delivery, accelerate start-up, strengthen evidence generation, and elevate the patient experience, it sets a new standard for how dermatology trials are conducted. By connecting every stakeholder across the dermatology research journey, OptimaDerm Suite turns complexity into coordinated, patient-centred progress

30+ Dermatology Projects
Distribution of Optimapharm dermatology projects by indication

Strategic Advisory Board

Dr. Pavle Vukojević

Dr. Pavle Vukojević

Chief Medical Officer

Dr. Gerald Klein

Dr. Gerald Klein

Medical Advisor, Haematology

Mira Patel

Mira Patel

Clinical Imaging, Dermatology

Dr. Katarina Andjelkov

Dr. Katarina Andjelkov

Medical Advisor, Aesthetics

Patient Advisory Board

Optimapharm has established a dedicated Patient Advisory Board, which we actively collaborate with and support to ensure patients' perspectives are reflected throughout development. By embedding their voice into clinical trial protocols and study execution, we help shape research that is more accessible, meaningful and aligned with the needs of those it aims to serve

Optimapharm Patient Advisory Board members
Sandra Silva-Arrieta, Patient Advisory Board Lead at Optimapharm

We Proudly Support

PAPAA (Psoriasis and Psoriatic Arthritis Alliance) - patient advocacy partner

Site & Patient Referral Networks

Optimapharm strategically partners with diverse site networks, including community-based recruitment organisations, site management organisations, and leading hospital systems, to deliver faster and more seamless study execution. With twice the reach across North America and Europe compared with the average mid-sized CRO, we expand access to patients where they live and receive care, enabling broader enrolment and real-world representation. These collaborative partnerships drive accelerated start-up, stronger referral pathways and a consistently high-performing site experience.

Hybrid and decentralised rare disease trial delivery network
Accelerated study start-up through site network partnerships
Patient reach compared with the average mid-sized CRO

2xThe reach of the average mid-sized CRO in North America and Europe

Healthcare professional supporting a clinical trial patient

Accelerating delivery through patient reach and expanded access to regulatory frameworks

Data Visualisations

BI WIZARD analytics dashboard

BI Wizard is our custom-built analytics solution, developed and powered by Microsoft Power BI. It leverages Power BI's robust business intelligence platform to visualise data, share insights, and provide interactive dashboards and reports. With BI Wizard, both Optimapharm and our sponsors can easily explore and interact with data, supporting informed, data-driven decision-making on all sides

Operational Insights

Example Report (Enrolment)
Example BI WIZARD enrolment report

Patient Profiling

Example Report (Blood Pressure)
Example BI WIZARD patient profiling report - blood pressure

Endpoint & Outcome Measures

Central Imaging

Central Imaging
Clinical Endpoints with Validated Imaging Tools
Image focused Clinician and Patient reported outcomes
Advanced Clinical Photography Systems and Objective measurements
STRATEGIC PARTNER
Canfield - dermatology imaging strategic partner

Central Laboratory

Central Laboratory
CAP Certified global laboratories
PBMC Network
Large range of Broad Biomarker Capabilities
STRATEGIC PARTNER
mlm medical labs - central laboratory strategic partner

Resource Hub